GPT and neoplasm: Specifically, compared to patients with ALT-positive tumours, those with ALT−/Tel− or with telomerase-positive tumours had a 0.19-fold (95% confidence limit (CL), 0.04–0.94, P=0.042) and a 0.38-fold (95% CL, 0.10–1.53, P=0.17) hazard of death.